Clinical Trials Browser

OTHER × Radiation Dose Hypofractionation × Thoracic × Clear all

NCT07358676 2026-01-22

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06379087 2025-07-10

Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05136846 2025-06-04

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer

Phase 1 Recruiting

Lung Neoplasms

NCT00983307 2025-04-30

A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer

Phase 2 Completed

17 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT03035890 2025-04-01

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

Phase NA Completed

35 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05443646 2024-05-07

Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

Phase 2 Recruiting

Limited Stage Small Cell Lung Cancer

NCT05161533 2023-10-18

Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial

Phase 2 Withdrawn

Lung Neoplasms

NCT05451173 2023-10-03

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03509584 2023-06-15

Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung

NCT04372927 2023-06-13

ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy

Phase 2 Terminated

1 enrolled 10 charts

Lung Neoplasms

NCT03833193 2023-03-23

Moderate Hypofractionated Radiotherapy for Lung Cancer

Phase NA Unknown

Lung Neoplasms

NCT03663764 2021-12-10

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Phase 2 Unknown

Thymoma

NCT02701400 2021-06-22

Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer

Phase 2 Completed

18 enrolled 13 charts

Small Cell Lung Carcinoma

NCT04543890 2020-09-10

CTV

Phase 2 Unknown

Small Cell Lung Cancer Limited Stage

NCT02672033 2020-07-24

Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma

Phase NA Terminated

2 enrolled 7 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02463994 2019-02-08

A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC

Phase EARLY_PHASE1 Completed

Carcinoma, Non-Small-Cell Lung

NCT02947113 2017-11-30

HYPOLAN

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01936961 2017-06-27

I-CREST

Phase NA Withdrawn

BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Neoplasms, Triple Negative Breast Neoplasms